FAMPYRA — Total Revenue
Biogen FAMPYRA — Total Revenue decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $300.00K to $0.00. Over 4 years (FY 2021 to FY 2025), FAMPYRA — Total Revenue shows a downward trend with a -66.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase in revenue signals strong market adoption, successful commercial execution, or effective lifecycle management, while a decrease may indicate increased competition, patent expiration, or declining patient demand.
Detailed definition
This metric represents the total gross revenue generated from the sale of a specific pharmaceutical product or therapeut...
Peer comparison
Comparable to product-specific revenue lines reported by other biopharmaceutical companies, often evaluated against therapeutic area benchmarks and patent exclusivity timelines.
biib_segment_fampyra_total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $26.10M | $26.20M | $26.30M | $26.20M | $25.50M | $22.00M | $22.90M | $24.10M | $23.40M | $20.00M | $23.00M | $19.20M | $18.70M | $19.40M | $14.40M | $300.00K | $0.00 | $0.00 | $1.10M | $0.00 |
| QoQ Change | — | +0.4% | +0.4% | -0.4% | -2.7% | -13.7% | +4.1% | +5.2% | -2.9% | -14.5% | +15.0% | -16.5% | -2.6% | +3.7% | -25.8% | -97.9% | -100.0% | — | — | -100.0% |
| YoY Change | — | — | — | — | -2.3% | -16.0% | -12.9% | -8.0% | -8.2% | -9.1% | +0.4% | -20.3% | -20.1% | -3.0% | -37.4% | -98.4% | -100.0% | -100.0% | -92.4% | -100.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's fampyra — total revenue?
- Biogen (BIIB) reported fampyra — total revenue of $0.00 in Q1 2026.
- How has Biogen's fampyra — total revenue changed year-over-year?
- Biogen's fampyra — total revenue decreased by 100.0% year-over-year, from $300.00K to $0.00.
- What is the long-term trend for Biogen's fampyra — total revenue?
- Over 4 years (2021 to 2025), Biogen's fampyra — total revenue has grown at a -66.0% compound annual growth rate (CAGR), from $105.20M to $1.40M.
- What does fampyra — total revenue mean?
- The total sales revenue generated by a specific pharmaceutical product.